CG Oncology, Inc. Common stock (CGON) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.1B | 759.48M | 695.79M | 673.03M | 701.19M | 754.21M | 552.08M | 563.86M | 578.61M | 194.12M | 209.71M | 143.48M | 147.21M |
| Cash & Short-Term Investments | 1.08B | 742.15M | 680.26M | 661.05M | 688.43M | 742M | 540.71M | 552.88M | 566.51M | 187.67M | 203.75M | 143.48M | 143.48M |
| Cash Only | 33.7M | 32.49M | 45.15M | 14.62M | 41.47M | 257.07M | 43.41M | 25.16M | 77.47M | 8.27M | 10.27M | -143.48M | 88.14M |
| Short-Term Investments | 1.04B | 709.66M | 635.12M | 646.43M | 646.96M | 484.93M | 497.3M | 527.72M | 489.04M | 179.41M | 193.48M | 286.96M | 55.34M |
| Accounts Receivable | 1.27M | 688K | 515K | 562K | 345K | 781K | 137K | 0 | 0 | 92K | 1K | 0 | 303K |
| Days Sales Outstanding | 81.57 | 23.83 | 29.74 | - | 974.42 | 92.61 | 293.12 | - | - | 4.28K | 10.14 | - | - |
| Inventory | 1.49M | 1.56M | 1.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 46.46 | 48.4 | 87.57 | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 23.13M | 15.07M | 13.51M | 0 | 12.41M | 11.43M | 11.23M | 182K | 153K | 6.36M | 5.96M | 0 | 3.42M |
| Total Non-Current Assets | 33.12M | 32.12M | 34.12M | 28.41M | 26.99M | 587K | 391K | 466K | 498K | 5.18M | 2.18M | -143.48M | 539K |
| Property, Plant & Equipment | 19.59M | 19.57M | 19.53M | 1.22M | 1.3M | 493K | 338K | 413K | 445K | 491K | 550K | 0 | 506K |
| Fixed Asset Turnover | 0.06x | 0.12x | 0.16x | - | 0.06x | 1.10x | 0.11x | 0.26x | 1.13x | 0.00x | 0.02x | - | - |
| Goodwill | 10.3M | 10.3M | 12.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 560K | 575K | 1.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.68M | 1.68M | 114K | 27.2M | 25.69M | 94K | 53K | 53K | 53K | 4.69M | 1.63M | -143.48M | 33K |
| Total Assets | 1.14B | 791.59M | 729.91M | 701.45M | 728.18M | 754.8M | 552.47M | 564.33M | 579.11M | 199.3M | 211.88M | 0 | 147.75M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - | - |
| Asset Growth % | 55.9% | 4.87% | 32.12% | 24.3% | 25.74% | 278.72% | 160.74% | - | - | 34.89% | - | - | - |
| Total Current Liabilities | 35.22M | 30.84M | 30.53M | 30.38M | 22.64M | 21.37M | 15.63M | 11.85M | 9.98M | 14.25M | 11.7M | 0 | 15.43M |
| Accounts Payable | 8.24M | 5.71M | 9.19M | 7.13M | 6.73M | 6.52M | 4.08M | 4.49M | 4.66M | 3.24M | 1.96M | 0 | 985K |
| Days Payables Outstanding | 211.93 | 235.32 | 475.98 | - | - | - | - | - | 89.86K | 59.83K | 15.25 | - | 89.88K |
| Short-Term Debt | 1.07M | 915K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 569K | 0 | 0 | 8.97M |
| Deferred Revenue (Current) | 0 | 0 | 259K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 25.91M | 24.21M | 6.63M | 241K | 2.82M | 436K | 5.02M | 131K | 282K | 547K | 4.36M | 0 | 173K |
| Current Ratio | 31.30x | 24.63x | 22.79x | 22.15x | 30.97x | 35.30x | 35.32x | 47.57x | 57.95x | 13.62x | 17.92x | - | 9.54x |
| Quick Ratio | 31.25x | 24.58x | 22.74x | 22.15x | 30.97x | 35.30x | 35.32x | 47.57x | 57.95x | 13.62x | 17.92x | - | 9.54x |
| Cash Conversion Cycle | -83.91 | -163.09 | -358.68 | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 8.27M | 8.15M | 11.74M | 706K | 781K | 52K | 71K | 118K | 184K | 257K | 315K | 0 | 7.14M |
| Long-Term Debt | 6.51M | 6.11M | 3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.53M |
| Capital Lease Obligations | 0 | 0 | 3.33M | 706K | 781K | 52K | 71K | 118K | 184K | 244K | 302K | 0 | 257K |
| Deferred Tax Liabilities | 307K | 307K | 1.61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.45M | 1.74M | 3.8M | 0 | 0 | 0 | 0 | 0 | 0 | 13K | 13K | 0 | 352K |
| Total Liabilities | 43.48M | 38.99M | 42.27M | 31.09M | 23.42M | 21.42M | 15.7M | 11.97M | 10.17M | 14.51M | 12.02M | 0 | 22.57M |
| Total Debt | 7.58M | 7.02M | 7.24M | 994K | 1.04M | 238K | 296K | 355K | 404K | 1.03M | 517K | 0 | 15.94M |
| Net Debt | -26.13M | -25.47M | -37.9M | -13.63M | -40.44M | -256.83M | -43.12M | -24.8M | -77.06M | -7.24M | -9.76M | 143.48M | -72.2M |
| Debt / Equity | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | - | 0.13x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.09B | 752.6M | 687.64M | 670.36M | 704.76M | 733.38M | 536.77M | 552.36M | 568.94M | 184.79M | 199.87M | 125.18M | 125.18M |
| Equity Growth % | 54.92% | 2.62% | 28.11% | 21.36% | 23.87% | 296.87% | 168.56% | - | 354.51% | 47.62% | - | - | - |
| Book Value per Share | 12.92 | 9.74 | 8.96 | 8.79 | 9.25 | 11.31 | 7.99 | 8.29 | 8.54 | 2.77 | 3.00 | 1.88 | 1.88 |
| Total Shareholders' Equity | 1.09B | 752.6M | 687.64M | 670.36M | 704.76M | 733.38M | 536.77M | 552.36M | 568.94M | 184.79M | 199.87M | 125.18M | 125.18M |
| Common Stock | 9K | 8K | 8K | 8K | 8K | 8K | 7K | 7K | 7K | 0 | 1K | 0 | 0 |
| Retained Earnings | -439.18M | -378.98M | -337.67M | -293.86M | -252.43M | -217.98M | -186.18M | -165.78M | -146.87M | -129.94M | -113.83M | 0 | -81.33M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -77.69M | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |